by Alison Bass | Feb 2, 2011 | Uncategorized
The Journal of the American Academy of Child and Adolescent Psychiatry has refused to retract a study finding that the antidepressant Paxil was safe and effective in adolescents despite evidence of fabrication, plagiarism and failure to disclose conflicts of interest...
by Alison Bass | Jan 21, 2011 | Uncategorized
The retraction of questionable scientific papers seems to be on the rise, due in large part to increased media scrutiny of scientific misconduct and conflicts of interest among researchers who fail to disclose they have skin in the game, i.e. lucrative financial ties...
by Alison Bass | Jan 18, 2011 | Uncategorized
On Wednesday, Jan. 19, I’m moderating a panel on blogging about health and science, sponsored by the New England Science Writers. We are fortunate to have attracted some top-notch bloggers, including Gary Schwitzer, whose HealthNewsReview blog was named the best...
by Alison Bass | Jan 12, 2011 | Uncategorized
For weeks now, The Boston Globe has been running stories about Sanofi Aventi’s hostile bid to acquire Genzyme, the Boston-based biotech giant. One recent story talked about how the CEOs of both companies attended the same conference in San Francisco without...
by Alison Bass | Jan 6, 2011 | Uncategorized
Just last night, a friend of mine mentioned that an acquaintance of hers, a woman in her 50s who was taking prescription drugs for several conditions including diabetes and high blood pressure, died from an overdose of legally prescribed drugs. Which is why I was not...
by Alison Bass | Dec 16, 2010 | Uncategorized
Over the past two years there has been a steady diet of books and media reports about the disturbing influence the pharmaceutical industry has on medical research and doctors’ prescribing patterns. Not a week goes by without a new report on the marketing muscle...
